Archive | BIOTRONIK

BIOTRONIK - Archive

2020
September
17,
2020
| 19:30 PM Europe/Amsterdam
Almost 30 years after the US FDA rescinded a ban on women of “childbearing potential” from participating in clinical studies, women remain underrepresented in many key areas for medical trials—including cardiovascular medicine. This is despite guidan...
Read more
June
19,
2020
| 20:50 PM Europe/Amsterdam
CardioMessenger devices form an essential part of BIOTRONIK’s remote monitoring system, enabling the secure transmission of critical patient and device data to the treating physician. As the company that pioneered remote monitoring, we have taken cyb...
Read more
June
01,
2020
| 16:00 PM Europe/Amsterdam
BIOTRONIK today announced that it has received a group purchasing contract from Vizient, Inc., the largest, member-driven, healthcare performance improvement company in the United States. The contract increases access to BIOTRONIK’s proven, trusted v...
Read more
May
27,
2020
| 18:50 PM Europe/Amsterdam
Results recently published in the Journal of Cardiovascular Electrophysiology confirm that BIOTRONIK's unique two-lead CRT-DX system provides equivalent therapy to more conventional three-lead systems. CRT-DX systems consist of a CRT-DX pulse generat...
Read more
April
17,
2020
| 14:41 PM Europe/Amsterdam
When Hannah was diagnosed with a complete heart block, her mom knew it was time to take action. She wrote to Heartbeat International Foundation and the next month Hannah received a BIOTRONIK pacemaker that restored her confidence. ...
Read more
April
01,
2020
| 21:27 PM Europe/Amsterdam
As the COVID-19 pandemic continues, we are conscious of the enormous strain that you are all under. We share your concerns about the spread of the virus and the disruption it is causing globally. We are doing what we can to help minimize this disrupt...
Read more
February
24,
2020
| 13:48 PM Europe/Amsterdam
BIOTRONIK today announced three-year data from the BIOFLOW-V trial, which was presented yesterday at the 2020 CRT Congress. The three-year follow-up data demonstrates consistently lower clinical event rates and improvement in patient outcomes, reinfo...
Read more
February
05,
2020
| 17:46 PM Europe/Amsterdam
Dr. Raffaele Corbisiero, Cardiac Electrophysiologist, Burlington County, New Jersey, weaves together some medical poetry as he explains the function of the autonomic nervous system and how BIOTRONIK's Closed Loop Stimulation (CLS) interacts with it w...
Read more
January
27,
2020
| 13:41 PM Europe/Amsterdam
BIOTRONIK, Inc. today announced the appointment of David Hayes, MD, FACC, as Chief Medical Officer. Dr. Hayes will oversee the development of BIOTRONIK’s cardiovascular solutions with a focus on advancing unique, proven innovations that help physicia...
Read more
2019
July
31,
2019
| 13:58 PM Europe/Amsterdam
BIOTRONIK today announced the company’s PK Papyrus® covered coronary stent system1 has been named a finalist in the 2019 Prix Galien USA Awards Ceremony for Best Medical Technology. PK Papyrus is used in emergency situations to create a physical b...
Read more
July
22,
2019
| 13:35 PM Europe/Amsterdam
BIOTRONIK today announced the publication of the SENSE Trial results in the Journal of Cardiac Electrophysiology, proving BIOTRONIK’s DX system is equivalent to dual-chamber implantable cardioverter defibrillators (ICDs) in detecting atrial high-rate...
Read more
July
08,
2019
| 13:48 PM Europe/Amsterdam
BIOTRONIK today announced FDA clearance of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is designed to document suspected arrhythmia or unexplained syncope with increased clarity, enabling fast diagnosis and appropriate treatme...
Read more
May
06,
2019
| 13:53 PM Europe/Amsterdam
BIOTRONIK today announced initial enrollment into the BIO-LIBRA study, a first-of-its kind, large-scale prospective study to analyze sex-specific outcomes in patients with non-ischemic cardiomyopathy (NICM) treated with cardiac defibrillator device t...
Read more
April
29,
2019
| 14:02 PM Europe/Amsterdam
BIOTRONIK today announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Leading electrophysiologists throughout the United States are now treating patients with the new implantable cardioverter defi...
Read more
April
10,
2019
| 14:05 PM Europe/Amsterdam
BIOTRONIK today announced the United States (US) commercial launch of the PK Papyrus® covered coronary stent system for use in the emergency treatment of acute coronary perforations.1,2 More than 800,000 percutaneous coronary intervention procedur...
Read more
March
14,
2019
| 14:11 PM Europe/Amsterdam
BIOTRONIK today announced FDA approval of the Acticor and Rivacor high-voltage cardiac rhythm management (CRM) device families for treatment of patients with cardiac arrhythmias. The six new tachycardia solutions include Rivacor VR-T, Rivacor DR-T, R...
Read more
February
25,
2019
| 14:44 PM Europe/Amsterdam
BIOTRONIK today announced FDA approval of the Orsiro drug-eluting stent (DES) system. Orsiro is the first and only ultrathin DES to outperform the clinical standard, Xience.1,2 Orsiro received CE marking in 2011 and has been used to treat more than o...
Read more
2018
September
24,
2018
| 19:25 PM Europe/Amsterdam
Today, BIOTRONIK announced two-year data from the BIOFLOW-V randomized trial comparing the Orsiro and Xience1 drug-eluting stents (DES). The data shows statistically improved outcomes for patients treated with Orsiro across a range of clinical endpoi...
Read more
September
14,
2018
| 19:30 PM Europe/Amsterdam
BIOTRONIK today announced the FDA approval of the PK Papyrus covered coronary stent system under Humanitarian Device Exemption for use in the emergency treatment of acute coronary perforations.1,2 PK Papyrus received CE marking in 2013. Built on B...
Read more
August
27,
2018
| 19:39 PM Europe/Amsterdam
BIOTRONIK today announced that the company is now the exclusive US distributor for InfoBionic’s MoMe Kardia external cardiac diagnostic monitor. The device benefits patients suspected of experiencing cardiac arrhythmias. Patients experiencing card...
Read more
April
03,
2018
| 19:46 PM Europe/Amsterdam
BIOTRONIK US and Aziyo today announced a strategic agreement allowing BIOTRONIK to distribute Aziyo’s CanGaroo® extracellular matrix (ECM) cardiovascular implantable electronic device (CIED) envelopes in the United States. BioEnvelope will be availab...
Read more